• Explore /
  • Poster
  • / Consolidative radiotherapy for metastatic urothelial bladder cancer patients without progression and with no more than three residual metastatic lesions following first line systemic therapy: A prospective randomized comparative phase II trial (BLAD RAD01/GETUG-AFU V07).

Consolidative radiotherapy for metastatic urothelial bladder cancer patients without progression and with no more than three residual metastatic lesions following first line systemic therapy: A prospective randomized comparative phase II trial (BLAD RAD01/GETUG-AFU V07).

Abstract Poster

Authors

null

Jonathan Khalifa

Institut Claudius Regaud/IUCT-Oncopole, Toulouse, France

Jonathan Khalifa , Damien Pouessel , Mathieu Roumiguie , Paul Sargos , Genevieve Loos , Ulrike Schick , Naji Salem , Nathalie Mesgouez-Nebout , Yohann Loriot , Christophe Hennequin , Emmanuel Meyer , Pierre Blanchard , Valentine Guimas , Laurent Votron , Pierre Graff-Cailleaud , Gilles Crehange , Muriel Mounier , Angélique Massoubre , Leonor Chaltiel , Thomas Filleron

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT04428554

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4588)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4588

Abstract #

TPS4588

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Amélie Aboudaram

First Author: Corbin J. Eule

First Author: Giulio Francolini

First Author: Hizra Farrukh